Standard BioTools Inc. (LAB) Financials

LAB Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 639.1 million 78.0 million
Dec. 31, 2025 567.8 million 143.5 million
Sept. 30, 2025 539.6 million 140.0 million
June 30, 2025 557.0 million 132.4 million

LAB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -47.2 million 8.8 million
Dec. 31, 2025 -1.7 million 5.7 million
Sept. 30, 2025 -23.1 million 7.5 million
June 30, 2025 -22.6 million 5.4 million

LAB Net Income

No data available :(

LAB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 455.2 million 24.0 million -
Dec. 31, 2025 187.6 million 299000 25.0 million
Sept. 30, 2025 194.9 million 299000 27.1 million
June 30, 2025 237.1 million 299000 28.3 million

LAB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 388.2 million
Dec. 31, 2025 385.0 million
Sept. 30, 2025 382.6 million
June 30, 2025 380.5 million

LAB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 570000 2.1 million 18.6 million -
Dec. 31, 2025 476000 8.0 million 25.3 million -
Sept. 30, 2025 886000 6.4 million 26.6 million -
June 30, 2025 1.9 million 6.2 million 28.1 million -

LAB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 21.1 million 9.8 million
Dec. 31, 2025 3.2 million 532000
Sept. 30, 2025 19.6 million 10.1 million
June 30, 2025 21.8 million 11.1 million

LAB Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LAB

Price: $0.84

52 week price:
0.80
1.72

Earnings Per Share: -0.13 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 454.8 million

Links: